Comparison of Cystic Fibrosis–Related Diabetes With Type 1 Diabetes Based on a German/Austrian Pediatric Diabetes Registry
暂无分享,去创建一个
[1] S. Hameed,et al. Cystic Fibrosis Related Diabetes (CFRD)—The End Stage of Progressive Insulin Deficiency , 2011, Pediatric pulmonology.
[2] 刘欣,et al. Clinical care guidelines for cystic fibrosis-related diabetes:a position statement of the Americal Diabetess Association and a clinical practice guideline of the Cystic Fibrosis Foundation ,endorsed by the pedistric Endocrine Society , 2011 .
[3] J. Rosenbauer,et al. [Frequency and influencing factors of ketoacidosis at diabetes onset in children and adolescents--a long-term study between 1995 and 2009]. , 2011, Klinische Padiatrie.
[4] M. S. Kirkman,et al. Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis–Related Diabetes , 2010, Diabetes Care.
[5] K. Robinson,et al. Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes , 2010, Diabetes Care.
[6] A. Moran,et al. Managing diabetes in cystic fibrosis , 2010, Diabetes, obesity & metabolism.
[7] R. Holl,et al. Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender‐specific increase of cardiovascular risk factors , 2010, Pediatric diabetes.
[8] A. Moran,et al. Recent trends in cystic fibrosis-related diabetes , 2010, Current opinion in endocrinology, diabetes, and obesity.
[9] M. Dattani,et al. Cystic Fibrosis-Related Diabetes in Childhood , 2010, Hormone Research in Paediatrics.
[10] S. Prasad,et al. Growth in children with cystic fibrosis‐related diabetes , 2009, Pediatric pulmonology.
[11] A. Moran,et al. Management of cystic fibrosis‐related diabetes in children and adolescents , 2009, Pediatric diabetes.
[12] J. Pilewski,et al. Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia , 2009, Diabetes Care.
[13] J. Rosenbauer,et al. Ketoacidosis at Diabetes Onset Is Still Frequent in Children and Adolescents , 2009, Diabetes Care.
[14] A. Moran,et al. Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality , 2009, Diabetes Care.
[15] J. Rice,et al. Use of the insulin pump in treat cystic fibrosis related diabetes. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[16] G. Cutting,et al. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. , 2009, The Journal of clinical endocrinology and metabolism.
[17] Y. Berthiaume,et al. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. , 2008, Diabetes & metabolism.
[18] H. Pijl,et al. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[19] G. Velho,et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. , 2008, The Journal of pediatrics.
[20] J. Rosenbauer,et al. Metabolic control as reflectet by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade , 2008, European Journal of Pediatrics.
[21] H. Lai. Classification of nutritional status in cystic fibrosis , 2006, Current opinion in pulmonary medicine.
[22] J. Janosky,et al. Longitudinal Study of Physiologic Insulin Resistance and Metabolic Changes of Puberty , 2006, Pediatric Research.
[23] G. Onady,et al. Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study , 2006, BMC endocrine disorders.
[24] S. Butler,et al. Epidemiology of cystic fibrosis-related diabetes. , 2005, The Journal of pediatrics.
[25] T. Reinehr,et al. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity , 2005, Pediatric diabetes.
[26] L. Harrison,et al. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity , 2005, Pediatric diabetes.
[27] Franz Schweiggert,et al. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV , 2002, Comput. Methods Programs Biomed..
[28] A. Moran,et al. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. , 2001, Diabetes care.
[29] M. Polak,et al. Cystic fibrosis‐related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy * , 2001, Acta paediatrica.
[30] J. Müller,et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben , 2001, Monatsschrift Kinderheilkunde.
[31] A. Galli-Tsinopoulou,et al. Insulin improves clinical status of patients with cystic‐fibrosis‐related diabetes mellitus , 2001, Acta paediatrica.
[32] S. Bell,et al. Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. , 2000, JOP : Journal of the pancreas.
[33] R. Holl,et al. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients. , 1997, Journal of pediatric gastroenterology and nutrition.
[34] H. Bilo,et al. [Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based]. , 2011, Nederlands tijdschrift voor geneeskunde.
[35] J. Rosenbauer,et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. , 2008, European journal of pediatrics.
[36] R. Holl,et al. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis , 2005, European Journal of Pediatrics.
[37] Clinical Practice Recommendations 2005. , 2005, Diabetes care.
[38] D. Finegood,et al. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. , 2003, Diabetes care.
[39] R. Holl,et al. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. , 2000, Diabetes care.